$60m mozzie man

Written on the 9 September 2009

A MOSQUITO trap designed by a Burleigh Heads inventor is taking the sting out of a worldwide epidemic and is looking to achieve 400 per cent growth with sales of $60 million over the next five years.

Bantix Worldwide has just signed a $500,000 deal to export its signature product, the Mosquito Slayer Pro, to distributors in Dubai.

Another 20 countries, including Malaysia and Russia are now importing the product.

CEO Andrew Coventry, says it’s the only device in the world that kills between 83 and 98 per cent of the potentially deadly female mosquito.

“We are experiencing very major growth,” says Coventry.

“The basic plan was to get 1000 units into 24 countries, which would have netted us around $6 million in profit. We are now expecting growth of more than 400 per cent. Our main competitor in the US spent $35 million alone on advertising and they have gone under. We have spent $12,000 over six years on advertising.”

The unit is powered by a 12-volt battery and contains a ‘lure’ designed by Bantix Worldwide. It contains a mix of food stuffs that are injected with CO2 to attract the mosquito to the trap.

The company has completed its world-wide patent for the trap with Fisher Adams Kelly. The spread of diseases like Dengue and Ross River Fever and Malaria are widening. A recent outbreak of Dengue Fever in the northern regions of Queensland was upgraded to epidemic status by the State Government.

“I’m very proud of our product, it’s saving people’s lives,” says Coventry.


Latest News

VITA GROUP POSTS STEADY RESULTS DESPITE ROUGH YEAR

IT'S no secret Vita Group (ASX: VTG) has had a testing year, however the company has still managed to deliver ...

KOGAN BREAKS FORECASTS IN ITS FIRST YEAR OF PUBLICLY LISTED TRADE

RAISING the bar high in its first year as a publicly listed company, Kogan.com (ASX: KGN) has smashed its forecast...

CAMPLIFY MOTORS INTO THE UK MARKET

CARAVAN hire and RV sharing community Camplify has made its move in the European market, establishing its first op...

COCHLEAR R&D INVESTMENT DRIVES NEW PRODUCTS AND BOOSTS PROFIT AND REVENUE

COCHLEAR (ASX: COH) has boosted its 2017 full year net profit by 18 percent to $223.6 million and has forecast furthe...

Related News

WESFARMERS BOOKS BUMPER PROFIT BUT SUPERMARKET WAR HITS COLES' BOTTOM LINE

SUPERMARKET giant Coles has posted its biggest slide in earnings since it was acquired by Wesfarmers (ASX: WES) 10 ye...

ANALYSTS PREDICT WHAT AUSSIE LIVING IS LIKELY TO BECOME IN THE NEXT CENTURY

AS THE Australian population continues to grow, analysts are predicting what the country is likely to look like wi...

SEVEN WEST REPORTS MASSIVE LOSS AND CUTS CEO TIM WORNER'S PAY PACKET BY $450K

SEVEN West Media (ASX: SWM) has posted a full-year loss of $744.3 million and cut CEO Tim Worner's pay packet by ...

HOW MAKING MISTAKES AND PASSION SCORED WEIGHT LOSS PARTNERS A DEAL WITH SHARK TANK'S JANINE ALLIS

THEY partnered up to provide a scientific and targeted approach to dieting, and Kate Save and Geoff Draper cut Sha...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter